B.Y. Quantitative Medicine Limited
B. Y. Quantitative Medicine is a company focused on transforming cancer treatment through AI-powered solutions and quantitative personalized medicine. Their core technology utilizes big data science to analyze gene co-expression networks in cancer, aiming to enhance diagnosis and treatment strategies. They offer an RNA Co-expression Test (QGCT®) which identifies pathways promoting cancerous behavior to determine suitable treatment targets, distinguishing their approach from traditional dichotomous biomarker tests. The company is backed by over 40 years of scientific discoveries and aims to improve patient outcomes by expanding treatment choices.
B.Y. Quantitative Medicine Limited
B. Y. Quantitative Medicine is a company focused on transforming cancer treatment through AI-powered solutions and quantitative personalized medicine. Their core technology utilizes big data science to analyze gene co-expression networks in cancer, aiming to enhance diagnosis and treatment strategies. They offer an RNA Co-expression Test (QGCT®) which identifies pathways promoting cancerous behavior to determine suitable treatment targets, distinguishing their approach from traditional dichotomous biomarker tests. The company is backed by over 40 years of scientific discoveries and aims to improve patient outcomes by expanding treatment choices.